Healthcare
Pharmaceutical supply chain
API manufacturing, excipients, and fill-finish capacity for essential medicines.
Curated sector reports
Pharmaceutical supply chain
Healthcare·⚠ API concentration in India & China
Key chokepoints (3)
API manufacturing (India / China)
⚠ active chokepoint
A large share of generic APIs is sourced from a handful of Asian sites; inspections can halt batches.
Related tickers: DRREDDY
KSM & precursor chemicals
⚠ active chokepoint
Single-source KSMs create fragility during pollution crackdowns or export licensing.
Sterile fill-finish capacity
⚠ active chokepoint
Fill-finish slots are scarce; pandemic-era bottlenecks persist for new launches.